Glycaemic control in diabetics with haemoglobin variants Version 2
Research type
Research Study
Full title
Review of current practices of assessing glycaemic control in diabetic patients with haemoglobin variants at Medway NHS Foundation Trust
IRAS ID
203579
Contact name
Karen Williams
Contact email
Sponsor organisation
University of Greenwich
Duration of Study in the UK
0 years, 2 months, 29 days
Research summary
Diabetic patients are monitored how well they control their blood glucose levels over a period of three months by a test called HbA1c. However this test is not always used in patients with a different kind of haemoglobin ( oxygen carrying component), called a variant. Another test called fructosamine is normally used for this type of patients and is done at another site which takes time to get a result. This test also only shows how well controlled glucose levels are for a shorter time than the HbA1c test. The study aims to assess if patients with known variants can be monitored using HbA1c values obtained from the two machines we have in our hospital. This will save time and money and improve patient experience and outcome. This study will be conducted at the Medway Hospital and will last for about three months. Samples taken for diagnostic and or monitoring of diabetes will be used for this study.
REC name
London - Westminster Research Ethics Committee
REC reference
16/LO/2222
Date of REC Opinion
20 Dec 2016
REC opinion
Favourable Opinion